Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain

被引:161
作者
Butterfield, DA [1 ]
机构
[1] Univ Kentucky, Dept Chem, Ctr Membrane Sci, Lexington, KY 40506 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
关键词
proteomics; oxidative stress; Alzheimer's disease brain;
D O I
10.1016/j.brainres.2003.12.012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In Alzheimer's disease (AD) brain oxidative stress is observed indexed by several markers, among which are protein carbonyls and 3-nitrotvrosine. markers for protein oxidation. We hypothesized that identity of these oxidatively modified proteins would lead to greater understanding of some of the potential molecular mechanisms involved in neurodegeneration in this dementing disorder. Proteomics is all emerging method for identification of proteins, and its application to neurodegenerative disorders, especially AD, is just beginning. Posttranslational modification of brain proteins, particularly that due Of Oxidation of proteins, provides an effective means of screening a Subset of proteins within the brain proteome that likely reflects the extensive oxidative stress under which the AD brain exists, and this new methodology provides insights into mechanisms of neurodegeneration in and new therapeutic targets for AD. In this review, the use of proteomics to identify specifically oxidized proteins in AD brain is presented, from which new insights into mechanisms of neurodegeneration and synapse loss in this dementing disorder that is associated with oxidative stress have emerged. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 65 条
[1]   Mass spectrometry in proteomics [J].
Aebersold, R ;
Goodlett, DR .
CHEMICAL REVIEWS, 2001, 101 (02) :269-295
[2]  
Aksenov MY, 1996, J NEUROCHEM, V66, P2050
[3]   Protein oxidation in the brain in Alzheimer's disease [J].
Aksenov, MY ;
Aksenova, MV ;
Butterfield, DA ;
Geddes, JW ;
Markesbery, WR .
NEUROSCIENCE, 2001, 103 (02) :373-383
[4]  
[Anonymous], 1997, Neurobiol Aging, V18, pS1
[5]  
Butterfield D.A., 1997, ADV CELL AGING GERON, V2, P161
[6]   Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins [J].
Butterfield, DA ;
Kanski, J .
MECHANISMS OF AGEING AND DEVELOPMENT, 2001, 122 (09) :945-962
[7]  
Butterfield DA, 2002, NEUROBIOL AGING, V23, P655
[8]   Evidence of oxidative damage in Alzheimer's disease brain:: central role for amyloid β-peptide [J].
Butterfield, DA ;
Drake, J ;
Pocernich, C ;
Castegna, A .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (12) :548-554
[9]   Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration [J].
Butterfield, DA ;
Boyd-Kimball, D ;
Castegna, A .
JOURNAL OF NEUROCHEMISTRY, 2003, 86 (06) :1313-1327
[10]   Proteomics for the identification of specifically oxidized proteins in brain: Technology and application to the study of neurodegenerative disorders [J].
Butterfield, DA ;
Castegna, A .
AMINO ACIDS, 2003, 25 (3-4) :419-425